Previous Article
Reflections on Cancer Drug Development Strategies with Newly-Introduced Chinese Regulations
Reflections on Cancer Drug Development Strategies with Newly-Introduced Chinese Regulations

The global cancer drug market is set to maintain strong growth over the next decade due to factors su...

Next Article
NDA to BLA Transition Products, FDA List Grew Recently
NDA to BLA Transition Products, FDA List Grew Recently

FDA has reviewed and approved the majority of therapeutic biological products (i.e. Biotechnology Pro...